All In Biotech

Drug Trial Radar · NCT07201051

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Investigate Efficacy, Safety, Immunogenicity, and Pharmacokinetics, of GSK3862995B in Participants With Bronchiectasis

Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 363 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

363

Planned (sponsor's estimate)

Start

Oct 30, 2025

Primary completion

May 4, 2027

Study completion Dec 10, 2027

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Oct 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung disease. The study will also test how the body processes the drug and to check for any immune reactions. Participants will be divided into groups randomly to receive either one of two different doses of the study drug or a placebo. The main goal of the study is to see how well the drug works compared to the placebo in helping those with bronchiectasis.

Conditions

  • Bronchiectasis

Interventions

  • GSK3862995BDrug

    Participants will be administered with dose level 1 of GSK3862995B.

  • PlaceboDrug

    Participants will be administered with matching placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized rate of Exacerbations for GSK3862995B Dose Level 1 Following Repeat Doses Compared with PlaceboTime frame: Up to Week 48

Locations

134 sites in 12 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Mobile, Alabama · Recruiting

  • GSK Investigational Site

    Phoenix, Arizona · Recruiting

  • GSK Investigational Site

    La Palma, California · Recruiting

  • GSK Investigational Site

    Valencia, California · Recruiting

  • GSK Investigational Site

    Aurora, Colorado · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Naples, Florida · Recruiting

  • GSK Investigational Site

    Pembroke Pines, Florida · Recruiting

  • GSK Investigational Site

    Plantation, Florida · Recruiting

  • GSK Investigational Site

    St. Petersburg, Florida · Recruiting

  • GSK Investigational Site

    Tamarac, Florida · Recruiting

  • GSK Investigational Site

    Winter Park, Florida · Recruiting

  • GSK Investigational Site

    Hammond, Indiana · Recruiting

  • GSK Investigational Site

    New Orleans, Louisiana · Recruiting

  • GSK Investigational Site

    Rockville, Maryland · Recruiting

  • GSK Investigational Site

    St Louis, Missouri · Recruiting

  • GSK Investigational Site

    Henderson, Nevada · Recruiting

  • GSK Investigational Site

    New Hyde Park, New York · Recruiting

  • GSK Investigational Site

    Winston-Salem, North Carolina · Recruiting

  • GSK Investigational Site

    DuBois, Pennsylvania · Recruiting

  • GSK Investigational Site

    Anderson, South Carolina · Recruiting

  • GSK Investigational Site

    Rock Hill, South Carolina · Recruiting

  • GSK Investigational Site

    Spartanburg, South Carolina · Recruiting

  • GSK Investigational Site

    Union, South Carolina · Recruiting

  • GSK Investigational Site

    Franklin, Tennessee · Recruiting

  • GSK Investigational Site

    Knoxville, Tennessee · Recruiting

  • GSK Investigational Site

    Conroe, Texas · Recruiting

  • GSK Investigational Site

    Cypress, Texas · Recruiting

  • GSK Investigational Site

    Sugar Land, Texas · Recruiting

  • GSK Investigational Site

    Williamsburg, Virginia · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    CABA, Argentina · Recruiting

  • GSK Investigational Site

    CABA, Argentina · Recruiting

  • GSK Investigational Site

    Rosario Provincia de Santa FE, Argentina · Recruiting

  • GSK Investigational Site

    San Miguel de Tucumán, Argentina · Recruiting

  • GSK Investigational Site

    San Miguel de Tucumán, Argentina · Recruiting

  • GSK Investigational Site

    San Miguel de Tucumán, Argentina · Recruiting

  • GSK Investigational Site

    Santa Fe, Argentina · Recruiting

  • GSK Investigational Site

    Beijing, China · Recruiting

Showing 40 of 134 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.